CliffBio
small molecule

CLOTIC

CLOTRIMAZOLE

Loss of exclusivityMay 2042latest FDA-listed patent expiry
CompanyCARWIN PHARMACEUTICAL ASSOCIATES LLC

Drug detail

Brand nameCLOTIC
Active ingredientCLOTRIMAZOLE
Strength1%
Dosage formSOLUTION/DROPS
RouteOTIC
ModalitySmall molecule
FDA approvalSeptember 2025
Marketing statusRX

Listed patents

PatentExpiresType
12246006May 2042product

Regulatory exclusivity

CodeExpires
GAINSeptember 2037
GAINSeptember 2033
ODE-549September 2032
NPSeptember 2028

More from CARWIN PHARMACEUTICAL ASSOCIATES LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.